Lytix Biopharma AS (OSL:LYTIX)
Norway flag Norway · Delayed Price · Currency is NOK
8.90
-0.08 (-0.89%)
Aug 1, 2025, 4:25 PM CET

Accolade Revenue

Lytix Biopharma AS had revenue of 608.00K NOK in the twelve months ending March 31, 2025, down -95.81% year-over-year. In the year 2024, Lytix Biopharma AS had annual revenue of 11.13M with 178.98% growth.

Revenue (ttm)
608.00K
Revenue Growth
-95.81%
P/S Ratio
999.23
Revenue / Employee
76.00K
Employees
8
Market Cap
607.53M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202411.13M7.14M178.98%
Dec 31, 20233.99M-7.04M-63.82%
Dec 31, 202211.03M-8.28M-42.87%
Dec 31, 202119.31M15.23M373.91%
Dec 31, 20204.07M-2.27M-35.73%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition